HURA
TuHURA Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$159.21M
P/E Ratio
—
EPS
$-0.61
Beta
—
52W High
$3.90
52W Low
$0.41
50-Day MA
$2.24
200-Day MA
$1.93
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About TuHURA Biosciences Inc
TuHURA Biosciences Inc is an innovative biotechnology company at the forefront of developing cutting-edge immunotherapy solutions designed to transform the treatment landscape for cancer and autoimmune diseases. Leveraging a strong research pipeline, the company is focused on harnessing the full capabilities of the human immune system to improve patient outcomes and address unmet medical needs. With strategic partnerships and a commitment to pioneering technologies, TuHURA is well-positioned for long-term growth and value creation in the dynamic biopharmaceutical industry, aiming to become a key influencer in the future of healthcare.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-28.97M |
| Operating Margin | 0.00% |
| Return on Equity | -187.20% |
| Return on Assets | -81.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.35 |
| Price-to-Book | 6.92 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $63.68M |
| Float | $35.44M |
| % Insiders | 34.88% |
| % Institutions | 14.97% |
Historical Volatility
HV 10-Day
83.40%
HV 20-Day
89.96%
HV 30-Day
115.97%
HV 60-Day
120.34%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($8.40 target)
2
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026